Cargando…
P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL)
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429014/ http://dx.doi.org/10.1097/01.HS9.0000847740.08829.48 |
| _version_ | 1784779299942825984 |
|---|---|
| author | Zhu, H. Sha, Y. Miao, Y. Qin, S. Wu, W. Qiu, J. Mi, H. Yang, Y. Peng, C. Ding, C. Wang, Z. Fan, L. Xu, W. Li, J. |
| author_facet | Zhu, H. Sha, Y. Miao, Y. Qin, S. Wu, W. Qiu, J. Mi, H. Yang, Y. Peng, C. Ding, C. Wang, Z. Fan, L. Xu, W. Li, J. |
| author_sort | Zhu, H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429014 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290142022-08-31 P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL) Zhu, H. Sha, Y. Miao, Y. Qin, S. Wu, W. Qiu, J. Mi, H. Yang, Y. Peng, C. Ding, C. Wang, Z. Fan, L. Xu, W. Li, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429014/ http://dx.doi.org/10.1097/01.HS9.0000847740.08829.48 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhu, H. Sha, Y. Miao, Y. Qin, S. Wu, W. Qiu, J. Mi, H. Yang, Y. Peng, C. Ding, C. Wang, Z. Fan, L. Xu, W. Li, J. P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL) |
| title | P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL) |
| title_full | P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL) |
| title_fullStr | P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL) |
| title_full_unstemmed | P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL) |
| title_short | P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL) |
| title_sort | p1219: zanubrutinib, lenalidomide plus r-chop (zr2-chop) as the first-line treatment for non-gcb diffused large b-cell lymphoma (dlbcl) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429014/ http://dx.doi.org/10.1097/01.HS9.0000847740.08829.48 |
| work_keys_str_mv | AT zhuh p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT shay p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT miaoy p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT qins p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT wuw p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT qiuj p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT mih p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT yangy p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT pengc p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT dingc p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT wangz p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT fanl p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT xuw p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl AT lij p1219zanubrutiniblenalidomideplusrchopzr2chopasthefirstlinetreatmentfornongcbdiffusedlargebcelllymphomadlbcl |